Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHF 1535 spacer study in asthmatic children
2011-002060-24Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of beclometasone dipropionate + formoterol, beclomethasone dipropionate and formoterol in asthma (3 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: FEV1 AUC corrected by time over 12 hours. Started Oct 2011; status: completed.
02
Drugs
beclometasone dipropionate + formoterolbeclomethasone dipropionateformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2011-002060-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002060-24.